Indication
Exacerbation of chronic obstructive pulmonary disease
An exacerbation of chronic obstructive pulmonary disease is an acute, sustained worsening of respiratory symptoms—principally marked by increased dyspnea, cough, and sputum volume or purulence—in individuals with preexisting chronic obstructive pulmonary disease. Read more about Exacerbation of chronic obstructive pulmonary disease
78 drugs 67 manufacturers
Drugs that treat it
Common Exacerbation of chronic obstructive pulmonary disease therapies.
TERBUTALINE SULFATE
TERBUTALINE SULFATE
RAYOS (prednisone)
PREDNISONE
PREDNISONE
PREDNISONE INTENSOL (prednisone)
THEOPHYLLINE IN 5% DEXTROSE (theophylline in dextrose 5 % in water)
TERBUTALINE SULFATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAn exacerbation of chronic obstructive pulmonary disease is an acute, sustained worsening of respiratory symptoms—principally marked by increased dyspnea, cough, and sputum volume or purulence—in individuals with preexisting chronic obstructive pulmonary disease.
Affecting the lower respiratory tract and pulmonary vasculature, this clinical state is typically triggered by viral or bacterial respiratory tract infections or environmental pollutants.
Pathophysiologically, it is driven by acute amplification of airway and systemic inflammation, worsening airflow limitation, mucous hypersecretion, dynamic pulmonary hyperinflation, and ventilation-perfusion mismatch that can culminate in acute hypoxemic or hypercapnic respiratory failure.
- nih.gov
An exacerbation of chronic obstructive pulmonary disease is an acute, sustained worsening of respiratory symptoms—principally marked by increased dyspnea, cough, and sputum volume or purulence—in individuals with preexisting chronic obstructive pulmonary disease Affecting the lower respiratory tract and pulmonary vasculature, this clinical state is typically triggered by viral or bacterial respiratory tract infections or environmental pollutants Pathophysiologically, it is driven by acute amplif...
- nih.gov
Pathophysiologically, it is driven by acute amplification of airway and systemic inflammation, worsening airflow limitation, mucous hypersecretion, dynamic pulmonary hyperinflation, and ventilation-perfusion mismatch that can culminate in acute hypoxemic or hypercapnic respiratory failure
Personalize your experience
Follow Exacerbation of chronic obstructive pulmonary disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.